|Articles|March 1, 2009
Insulin pens and the blind
Recently, several manufacturers of insulin pens for diabetes treatment have added warnings to the devices, cautioning against their use by visually impaired patients.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy
5


















